Do we need tailored smoking cessation interventions for smokers with COPD? A comparative study of smokers with and without COPD regarding factors associated with tobacco smoking

Respiration

Volumn 90, Issue 3, 2015, Pages 211-219

  Van Eerd, Eva A M ^a   Van Rossem, Carolien R ^a   Spigt, Mark G ^a,b   Wesseling, Geertjan ^a   Van Schayck, Onno C P ^a   Kotz, Daniel ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Chronic obstructive pulmonary disease; Questionnaire survey; Smoking cessation; Smoking related factors; Tobacco smoking

Indexed keywords

AMFEBUTAMONE; NORTRIPTYLINE; VARENICLINE;

AGED; ARTICLE; BEHAVIOR THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; GENERAL PRACTITIONER; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; QUESTIONNAIRE; SELF CONCEPT; SMOKING; SMOKING CESSATION; SOCIAL ASPECT; ADAPTIVE BEHAVIOR; ADVERSE EFFECTS; AGE; CROSS-SECTIONAL STUDY; FOLLOW UP; LUNG FUNCTION TEST; MIDDLE AGED; NETHERLANDS; PATIENT COMPLIANCE; PROCEDURES; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PATIENT COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; SMOKING CESSATION; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84946219688     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000398816     Document Type: Article

References (41)

1. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR: An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010: 182: 693-718
2. National Institute for Public Health and Environment; Ministry of Health, Welfare and Sports: National Precept Public Health, 2014. http: //www.nationaalkompas.nl/ (accessed May 22, 2014
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2014. http: //www.goldcopd.org/ (accessed February 10, 2014
4. Willemse BW, Postma DS, Timens W, Ten Hacken NH: The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004: 23: 464-476
5. Anthonisen NR, Connett JE, Murray RP: Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002: 166: 675-679
6. Van Der Meer R, Wagena EJ, Ostelo R, Jacobs A, Van Schayck C: Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009: 1: CD002999
7. Shahab L, Jarvis MJ, Britton J, West R: Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006: 61: 1043-1047
8. Willemse B, Lesman-Leegte I, Timens W, Postma D, Ten Hacken N: High cessation rates of cigarette smoking in subjects with and without COPD. Chest 2005: 128: 3685-3687
9. Wagena EJ, Knipschild PG, Huibers MJ, Wouters EF, Van Schayck CP: Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med 2005: 165: 2286-2292
10. Stratelis G, Molstad S, Jakobsson P, Zetterstrom O: The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care 2006: 24: 133-139
11. Jimenez-Ruiz CA, Masa F, Miravitlles M, Gabriel R, Viejo JL, Villasante C, Sobradillo V: Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001: 119: 1365-1370
12. Vozoris NT, Stanbrook MB: Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med 2011: 105: 477-484
13. Eindhoven Corporation of Primary Health Care Centres, 2013. https: //www.sge.nl/.
14. Breslau N, Peterson EL: Smoking cessation in young adults: age at initiation of cigarette smoking and other suspected influences. Am J Public Health 1996: 86: 214-220
15. Borrelli B, Hayes RB, Dunsiger S, Fava JL: Risk perception and smoking behavior in medically ill smokers: a prospective study. Addiction 2010: 105: 1100-1108
16. Chaiton MO, Cohen JE, O Loughlin J, Rehm J: A systematic review of longitudinal studies on the association between depression and smoking in adolescents. BMC Public Health 2009: 9: 356
17. Bock BC, Jennings E, Becker BM, Partridge R, Niaura RS: Characteristics and predictors of readiness to quit among emergency medical patients presenting with respiratory symptoms. Int J Emerg Med 2011: 4: 24
18. Borland R, Yong HH, Balmford J, Cooper J, Cummings KM, O Connor RJ, McNeill A, Zanna MP, Fong GT: Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four country project. Nicotine Tob Res 2010: 12(suppl): S4-S11
19. Van Den Putte B, Yzer MC, Brunsting S: Social influences on smoking cessation: a comparison of the effect of six social influence variables. Prev Med 2005: 41: 186-193
20. Gwaltney CJ, Metrik J, Kahler CW, Shiffman S: Self-efficacy and smoking cessation: a metaanalysis. Psychol Addict Behav 2009: 23: 56-66
21. Ferguson JA, Patten CA, Schroeder DR, Offord KP, Eberman KM, Hurt RD: Predictors of 6-month tobacco abstinence among 1, 224 cigarette smokers treated for nicotine dependence. Addict Behav 2003: 28: 1203-1218
22. Mudde AN, Willemsen MC, Kremers S, De Vries H: Measurements for Research on Smoking Cessation. The Hague, STIVORO, 2000
23. Snaith RP, Zigmond AS: Hospital Anxiety and Depression Scale. Windsor, NFER-Nelson, 1994
24. Ware JE Jr, Gandek B: Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998: 51: 903-912
25. Van Der Molen T: Clinical COPD Questionnaire. Groningen, University Medical Center Groningen, 1999
26. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J: Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989: 84: 791-799
27. Boudrez H, De Bacquer D: A Dutch version of the modified reasons for smoking scale: factorial structure, reliability and validity. J Eval Clin Pract 2012: 18: 799-806
28. Kotz D, Huibers MJ, West RJ, Wesseling G, Van Schayck OC: What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD?. Patient Educ Couns 2009: 76: 16-24
29. Kotz D, Brown J, West R: Predictive validity of the Motivation to Stop Scale (MTSS): a single-item measure of motivation to stop smoking. Drug Alcohol Depend 2013: 128: 15-19
30. Klaassen A, Van Wensveen D: Survey - Continuous Investigation of Smoking Habits. The Hague, STIVORO, 2010
31. Stead LF, Bergson G, Lancaster T: Physician advice for smoking cessation. Cochrane Database Syst Rev 2008: 2: CD000165
32. Hilberink SR, Jacobs JE, Schlosser M, Grol RP, De Vries H: Characteristics of patients with COPD in three motivational stages related to smoking cessation. Patient Educ Couns 2006: 61: 449-457
33. Tonnesen P, Carrozzi L, Fagerstrom KO, Gratziou C, Jimenez-Ruiz C, Nardini S, Viegi G, Lazzaro C, Campell IA, Dagli E, West R: Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 2007: 29: 390-417
34. Borland R, Yong HH, Balmford J, Fong GT, Zanna MP, Hastings G: Do risk-minimizing beliefs about smoking inhibit quitting?. Findings from the International Tobacco Control (ITC) Four-Country Survey. Prev Med 2009: 49: 219-223
35. Mannino DM, Buist AS: Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007: 370: 765-773
36. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J: Smoking, smoking cessation, and major depression. JAMA 1990: 264: 1546-1549
37. Devins GM, Edwards PJ: Self-efficacy and smoking reduction in chronic obstructive pulmonary disease. Behav Res Ther 1988: 26: 127-135
38. Dijkstra A, Wolde GT: Ongoing interpretations of accomplishments in smoking cessation: positive and negative self-efficacy interpretations. Addict Behav 2005: 30: 219-234
39. Nagelhout GE, Willemsen MC, Van Den Putte B, De Vries H, Willems RA, Segaar D: Effectiveness of a national reimbursement policy and accompanying media attention on use of cessation treatment and on smoking cessation: a real-world study in the Netherlands. Tob Control 2014: 0: 1-7
40. Reda AA, Kotz D, Evers SM, Van Schayck CP: Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev 2012: 16: CD004305
41. STIVORO: Highlights - Smoking in the Netherlands 2012. The Hague, STIVORO, 2013